Acute hypercapnia improves indices of tissue oxygenation more than dobutamine in septic shock.
BACKGROUND
Hypercapnia has similar hemodynamic effects to those of a dobutamine infusion and may have relevance in the management of septic shock.


OBJECTIVE
To compare the effects induced by hypercapnia with those of dobutamine in a clinically relevant model of septic shock.


METHODS
Fecal peritonitis was induced in 21 anesthetized, invasively monitored, mechanically ventilated female sheep. A combination of Ringer's lactate and 6% hydroxyethyl starch solution was titrated to maintain constant cardiac filling throughout the experiments. Two hours after feces spillage, animals were randomized to one of three groups (each, n = 7): (1) hypercapnia: carbon dioxide given to maintain partial pressure of carbon dioxide between 55 and 65 mm Hg throughout the experiment; (2) dobutamine: dobutamine infused intravenously (7 microg/kg/min); (3) control: no treatment. In the dobutamine and control groups, the partial pressure of carbon dioxide was kept between 35 and 45 mm Hg. All animals were monitored until spontaneous death.


RESULTS
The animals in the hypercapnia group had significantly lower arterial pH than the other two groups (P < 0.05). Hypercapnic and dobutamine-treated animals developed significantly higher heart rate, cardiac index, and oxygen delivery, and lower lactate concentrations than control animals (P < 0.05). Hypercapnic animals had lower post mortem lung wet/dry ratio than the control animals (P < 0.05). The alveolar-arterial oxygen partial pressure difference and shunt fraction were significantly lower in hypercapnic animals than in the other groups (P < 0.05).


CONCLUSIONS
In this clinically relevant ovine model of septic shock, hypercapnia had similar effects to dobutamine on hemodynamic variables and lactic acidosis. Hypercapnia improved tissue oxygenation and reduced lung edema formation more than dobutamine administration.
Wang
Zhen
Z
Department of Intensive Care, Erasme Hospital, Route de Lennik 808, 1070-B Brussels, Belgium. jlvincen@ulb.ac.be.
Su
Fuhong
F
Bruhn
Alejandro
A
Yang
Xin
X
Vincent
Jean-Louis
JL
D000318:Adrenergic beta-Agonists / Q000627:therapeutic use*; D000818:Animals; D002245:Carbon Dioxide / Q000378:metabolism; D002302:Cardiac Output; D004195:Disease Models, Animal; D004280:Dobutamine / Q000627:therapeutic use*; D005260:Female; D006339:Heart Rate; D006935:Hypercapnia; D010100:Oxygen / Q000378:metabolism*; D012756:Sheep; D012772:Shock, Septic / Q000188:drug therapy / Q000378:metabolism / Q000628:therapy*
D000318:Adrenergic beta-Agonists; D002245:Carbon Dioxide; D004280:Dobutamine; D010100:Oxygen